Title : Effects of Fostamatinib on the Pharmacokinetics of Digoxin (a P-Glycoprotein Substrate): Results From in Vitro and Phase I Clinical Studies.

Pub. Date : 2015 Dec 1

PMID : 26514315






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The studies reported herein examined whether fostamatinib and R406 are inhibitors of P-glycoprotein (P-gp) in vitro and evaluated the effect of fostamatinib on the pharmacokinetic parameters of digoxin to understand drug-drug interaction (DDI) potential in the clinic. fostamatinib ATP binding cassette subfamily B member 1 Homo sapiens
2 METHODS: Inhibition of P-gp-mediated digoxin transport by fostamatinib and R406 was determined across Caco-2 cell monolayers. fostamatinib ATP binding cassette subfamily B member 1 Homo sapiens
3 FINDINGS: Fostamatinib (but not R406) was determined to be a P-gp inhibitor in vitro (IC50 = 3.2 muM). fostamatinib ATP binding cassette subfamily B member 1 Homo sapiens
4 IMPLICATIONS: Fostamatinib was confirmed to be a P-gp inhibitor in vitro and in vivo, and a DDI with digoxin was apparent. fostamatinib ATP binding cassette subfamily B member 1 Homo sapiens